...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Shareholder Value

"Zenith at $0.36 (a public company traded only on the OTC markets)"- Toinv

 

Are they really a "public company"?  Has anyone ever admitted those OTC shares actually confer ownership? 

Share
New Message
Please login to post a reply